NIAID funds Antigen Discovery for microfluidic POC device development
06:43 EDT 17 Aug 2012 | Medical Business Review
The National Institute of Allergy and Infectious Diseases (NIAID) of the US National Institutes of Health has awarded Phase I small business innovation research grant of $600,000 to Antigen Discovery to develop a microfluidic point of care (POC) diag..
Original Article: NIAID funds Antigen Discovery for microfluidic POC device development
More From BioPortfolio on "NIAID funds Antigen Discovery for microfluidic POC device development"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
